Literature DB >> 23983249

Depressing mitochondria-reticulum interactions protects cardiomyocytes from lethal hypoxia-reoxygenation injury.

Melanie Paillard1, Emily Tubbs, Pierre-Alain Thiebaut, Ludovic Gomez, Jeremy Fauconnier, Claire Crola Da Silva, Geoffrey Teixeira, Nathan Mewton, Elise Belaidi, Annie Durand, Maryline Abrial, Alain Lacampagne, Jennifer Rieusset, Michel Ovize.   

Abstract

BACKGROUND: Under physiological conditions, Ca(2+) transfer from the endoplasmic reticulum (ER) to mitochondria might occur at least in part at contact points between the 2 organelles and involves the VDAC1/Grp75/IP3R1 complex. Accumulation of Ca(2+) into the mitochondrial matrix may activate the mitochondrial chaperone cyclophilin D (CypD) and trigger permeability transition pore opening, whose role in ischemia/reperfusion injury is well recognized. We questioned here whether the transfer of Ca(2+) from ER to mitochondria might play a role in cardiomyocyte death after hypoxia-reoxygenation. METHODS AND
RESULTS: We report that CypD interacts with the VDAC1/Grp75/IP3R1 complex in cardiomyocytes. Genetic or pharmacological inhibition of CypD in both H9c2 cardiomyoblasts and adult cardiomyocytes decreased the Ca(2+) transfer from ER to mitochondria through IP3R under normoxic conditions. During hypoxia-reoxygenation, the interaction between CypD and the IP3R1 Ca(2+) channeling complex increased concomitantly with mitochondrial Ca(2+) content. Inhibition of either CypD, IP3R1, or Grp75 decreased protein interaction within the complex, attenuated mitochondrial Ca(2+) overload, and protected cells from hypoxia-reoxygenation. Genetic or pharmacological inhibition of CypD provided a similar effect in adult mice cardiomyocytes. Disruption of ER-mitochondria interaction via the downregulation of Mfn2 similarly reduced the interaction between CypD and the IP3R1 complex and protected against hypoxia-reoxygenation injury.
CONCLUSIONS: Our data (1) point to a new role of CypD at the ER-mitochondria interface and (2) suggest that decreasing ER-mitochondria interaction at reperfusion can protect cardiomyocytes against lethal reperfusion injury through the reduction of mitochondrial Ca(2+) overload via the CypD/VDAC1/Grp75/IP3R1 complex.

Entities:  

Keywords:  calcium; ischemia; reperfusion; sarcoplasmic reticulum

Mesh:

Substances:

Year:  2013        PMID: 23983249     DOI: 10.1161/CIRCULATIONAHA.113.001225

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  81 in total

1.  DJ-1 regulates the integrity and function of ER-mitochondria association through interaction with IP3R3-Grp75-VDAC1.

Authors:  Yi Liu; Xiaopin Ma; Hisashi Fujioka; Jun Liu; Shengdi Chen; Xiongwei Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-25       Impact factor: 11.205

2.  Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosis.

Authors:  Vincent Mignard; Nolwenn Dubois; Didier Lanoé; Marie-Pierre Joalland; Lisa Oliver; Claire Pecqueur; Dominique Heymann; François Paris; François M Vallette; Lisenn Lalier
Journal:  J Lipid Res       Date:  2020-04-29       Impact factor: 5.922

Review 3.  Metabolic implications of organelle-mitochondria communication.

Authors:  Isabel Gordaliza-Alaguero; Carlos Cantó; Antonio Zorzano
Journal:  EMBO Rep       Date:  2019-08-14       Impact factor: 8.807

4.  VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism.

Authors:  Hadar Klapper-Goldstein; Ankit Verma; Sigal Elyagon; Roni Gillis; Michael Murninkas; Srinivas Pittala; Avijit Paul; Varda Shoshan-Barmatz; Yoram Etzion
Journal:  Sci Rep       Date:  2020-12-16       Impact factor: 4.379

Review 5.  Sarcoplasmic reticulum-mitochondria communication in cardiovascular pathophysiology.

Authors:  Camila Lopez-Crisosto; Christian Pennanen; Cesar Vasquez-Trincado; Pablo E Morales; Roberto Bravo-Sagua; Andrew F G Quest; Mario Chiong; Sergio Lavandero
Journal:  Nat Rev Cardiol       Date:  2017-03-09       Impact factor: 32.419

Review 6.  Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.

Authors:  Hans Erik Bøtker; Derek Hausenloy; Ioanna Andreadou; Salvatore Antonucci; Kerstin Boengler; Sean M Davidson; Soni Deshwal; Yvan Devaux; Fabio Di Lisa; Moises Di Sante; Panagiotis Efentakis; Saveria Femminò; David García-Dorado; Zoltán Giricz; Borja Ibanez; Efstathios Iliodromitis; Nina Kaludercic; Petra Kleinbongard; Markus Neuhäuser; Michel Ovize; Pasquale Pagliaro; Michael Rahbek-Schmidt; Marisol Ruiz-Meana; Klaus-Dieter Schlüter; Rainer Schulz; Andreas Skyschally; Catherine Wilder; Derek M Yellon; Peter Ferdinandy; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2018-08-17       Impact factor: 17.165

7.  Study of Endoplasmic Reticulum and Mitochondria Interactions by In Situ Proximity Ligation Assay in Fixed Cells.

Authors:  Emily Tubbs; Jennifer Rieusset
Journal:  J Vis Exp       Date:  2016-12-10       Impact factor: 1.355

8.  Hyperglycemia-Driven Inhibition of AMP-Activated Protein Kinase α2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes In Vivo.

Authors:  Shengnan Wu; Qiulun Lu; Ye Ding; Yin Wu; Yu Qiu; Pei Wang; Xiaoxiang Mao; Kai Huang; Zhonglin Xie; Ming-Hui Zou
Journal:  Circulation       Date:  2019-04-16       Impact factor: 29.690

9.  Adrenergic signaling regulates mitochondrial Ca2+ uptake through Pyk2-dependent tyrosine phosphorylation of the mitochondrial Ca2+ uniporter.

Authors:  Jin O-Uchi; Bong Sook Jhun; Shangcheng Xu; Stephen Hurst; Anna Raffaello; Xiaoyun Liu; Bing Yi; Huiliang Zhang; Polina Gross; Jyotsna Mishra; Alina Ainbinder; Sarah Kettlewell; Godfrey L Smith; Robert T Dirksen; Wang Wang; Rosario Rizzuto; Shey-Shing Sheu
Journal:  Antioxid Redox Signal       Date:  2014-06-25       Impact factor: 8.401

Review 10.  Mitochondria-Associated Endoplasmic Reticulum Membranes (MAMs) and Their Prospective Roles in Kidney Disease.

Authors:  Peng Gao; Wenxia Yang; Lin Sun
Journal:  Oxid Med Cell Longev       Date:  2020-09-03       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.